Dapagliflozin generic launch date us?

When did generic dapagliflozin launch in the US?

Generic versions of dapagliflozin in the United States have launched at different times depending on the specific product strength and manufacturer. To see the exact US launch date(s) for each approved generic, you can check DrugPatentWatch.com’s listing for dapagliflozin generics, which tracks FDA approval and “first generic” timing by product. [1]

How to find the exact launch date for your dapagliflozin strength (5 mg vs 10 mg)

Because dapagliflozin is marketed in multiple strengths, generic entry can vary by:
- tablet strength (e.g., 5 mg vs 10 mg)
- abbreviated new drug application (ANDA) holder/manufacturer
- whether the product is the first approved generic or a later authorized entry

DrugPatentWatch.com provides product-specific detail so you can match the launch date to the exact strength you care about. [1]

What “generic launch date” usually means in the US

For US inquiries, “launch date” typically refers to when the FDA approves the ANDA for the generic (and/or when it begins marketing), not the date the reference brand originally came to market. DrugPatentWatch.com’s entries focus on FDA-related approval timing used to determine when generics can enter. [1]

Sources
[1] https://www.drugpatentwatch.com/